CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Masimo Centroid Systemdevice
Likely dose
Masimo Centroid System — noninvasive positional monitoring deviceAI-extracted
Key inclusion· 4
  • ✓At least 18 years of age
  • ✓ICU patient
  • ✓Primarily bedbound
  • ✓Able to be monitored for a minimum of approximately 8 hours
Key exclusion· 6
  • ✕Pregnancy
  • ✕Prisoner status
  • ✕Pressure injury stage 2, 3, or ungroupable
  • ✕Pacemaker or internal defibrillator

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03121144
NCT03121144N/ACompleted
CompareCT.gov

Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection

Masimo Corporation·interventional·Posted Apr 19, 2017·Updated Jun 1, 2020

In Brief

A clinical study evaluating Masimo Centroid System for Pressure Ulcer and 2 related conditions. Completed, enrolled 34 participants across 1 site.

Detailed Summary

This study describes a procedure to collect a subject's position, movement, physiological data and usability information using Masimo's investigational device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPressure Ulcer, Pressure Injury, Falls Injury
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 19, 2017
Enrollment StartMar 1, 2017
Primary CompletionMar 27, 2019
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.2 years ago

Interventions

Masimo Centroid Systemdevice

Noninvasive positional monitoring device